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Summary
A clinical trial conducted during the 
summer of 2006 evaluated the effects 
of two- and three-dose regimens of an 
Escherichia coli O157 vaccine product 
on the probability of detecting E. coli 
O157:H7 in feces and on colonization 
of the terminal rectum. The three-dose 
regimen significantly reduced the prob-
ability for cattle to shed E. coli O157:
H7 in feces by 63% compared to placebo 
treated cattle. A dose-effect was demon-
strated because a two-dose regimen of 
the vaccine product was intermediate in 
effect. These results are consistent with 
previous estimates of vaccine efficacy 
against fecal shedding and agree with 
our previous finding that efficacy is 
related to the number of doses.
Introduction
Vaccination of feedlot cattle 
against type III secreted proteins of 
Escherichia coli O157:H7 as a strategy 
to reduce the probability for cattle to 
shed the organism and effects of dose 
regimen has been reported in several 
beef reports (2006 Nebraska Beef 
Report, pp. 68-69; 2006 Nebraska Beef 
Report, pp. 70-71; 2005 Nebraska Beef 
Report, pp. 61-6). 
The issue of how many vaccine 
doses to administer for effectiveness 
is an important one for efficiency 
of cattle handling. Our 200 study 
tested the number of doses of vac-
cine administered to cattle within 
pens (2005 Nebraska Beef Report, pp. 
61-6). In that study, vaccination of 
a majority of cattle within the pen 
conferred protection to nonvaccinated 
animals within pens indicating a pen-
level effect of vaccination. In order 
to clarify the effect of the number of 
vaccine doses, a clinical trial was con-
ducted that compared the effects of 
two and three doses of vaccine against 
nonvaccinated animals, with vaccina-
tion treatment being applied to the 
pen rather than the individual animal 
as in the previous study. 
Procedure
The clinical trial was conducted 
from June to October of 2006 at the 
beef research feedlot of the University 
of Nebraska Agricultural Research 
and Development Center at Ithaca, 
Neb. Four hundred eighty medium 
weight steers were stratified by BW 
and randomly assigned to 60 pens 
(8 steers/pen). Twenty pens were 
assigned to each of three treatments: 
1) three doses of placebo given at days 
0, 21, and 42; 2) two doses of vac-
cine given at days 0 and 42; and ) 
three doses of vaccine given at days 
0, 21, and 42. Pens were managed in 
4 blocks to account for differences in 
date of first vaccination, vaccination-
to-slaughter intervals (15 or 16 weeks) 
and location within the feedlot facil-
ity. All animals were fed similar high-
moisture corn (HMC) diets with 20% 
wet corn gluten feed, 7.5% roughage, 
and 5.0% supplement. Blocks 1 and 2 
were comprised of 18 pens each, with 
each block treated and sampled at dif-
ferent times (block 2 was vaccinated 
one week later and slaughtered 1 week 
later than block 1). Block  was com-
posed of 9 pens with  pens per vac-
cine treatment. Block 4 was composed 
of 15 pens with 5 pens per treatment. 
Blocks  and 4 were treated and 
sampled on the same days but were in 
different locations within the feedlot. 
Vaccine and placebo treatments were 
coded by the manufacturer (Bioniche 
Life Sciences Inc.) so that researchers 
and feedlot personnel were blinded to 
treatment. 
Fecal samples were obtained from 
the rectum on days 0, 6, 77, 91 and 
the day prior to harvest (i.e., 1 pre-
treatment period and 4 test period 
samplings), and a sample of the termi-
nal rectum mucosa (TRM) was col-
lected at harvest. Fecal cultures from 
all steers were collected by block as 
stated above within the same test pe-
riod. Fecal samples were labeled with 
a bar-code and TRM samples were 
numbered in order of harvest, which 
blinded laboratory personnel to ani-
mal identification. All samples were 
transported to the laboratory within 
a few hours of collection. Standard 
broth enrichment and plate culture 
methods (2006 Nebraska Beef Report, 
pp. 68-69) with modifications were 
used to yield a positive or negative 
result and determination of the prob-
ability (prevalence) of E. coli O157:H7 
fecal shedding or TRM colonization. 
Serial dilution of weighed samples fol-
lowed by direct plating (i.e., without 
broth enrichment) and standard cul-
ture methods (2006 Beef Report, pp. 
68-69) with modifications were used 
to quantify E. coli O157:H7 CFU per 
gram of feces or TRM. 
The effect of vaccine treatment 
on the probability of detecting E. coli 
O157:H7 from feces was modelled 
using multi-level logistic regression 
(GENMOD, SAS Institute, Cary, 
N.C.). Least squared means of the 
parameter estimates from the multi-
variate analysis were used to estimate 
adjusted probabilities for vaccine 
treatment. Relative risk (RR) values 
for each vaccine treatment were calcu-
lated from the adjusted probabilities 
and vaccine efficacy was calculated as 
1-RR.
Results
Prevalence of E. coli O157:H7 fecal 
shedding
In this study E. coli O157:H7 was 
detected in 26 of 2,87 fecal samples 
(10%); 117 of 478 pre-treatment (24%) 
and 119 of 1,909 post-treatment fecal 
samples (6%) were culture positive. 
The prevalence of fecal shedding 
among all treatment groups declined 
during the feeding period, with a very 
slight increase at harvest (Figure 1). 
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E. coli O157:H7 was detected in 16 of 
415 pre-treatment samples (.9%); 
7 were from placebo-treated, 2 were 
from 2-dose-treated, and 7 were from 
-dose-treated pens of cattle. Mean 
(SEM) log
10
 bacterial counts (CFU/g) 
were .0 (0.8), .5 (0.50) and .2 
(0.41) for placebo-treated, 2-dose, and 
-dose treatment groups, respectively, 
suggesting that in cattle that were 
shedding, relatively similar amounts 
of the organism were shed. E. coli 
O157:H7 was detected in 1 of 1,546 
post-treatment samples (0.8%); 5 from 
placebo-treated, 4 from 2-dose, and 
4 from -dose treated pens of cattle. 
Mean (SE) log
10
 bacterial counts 
(CFU/g) were 2.6 (0.29), 4.1 (0.55), 
and .7, (0.64) for placebo-treated, 
2-dose, and -dose treatment groups, 
respectively.
Prevalence of E. coli O157:H7 Coloniza-
tion
At harvest, a total of 5 of 80 
(1.%) steers were colonized;  were 
placebo-treated and 2 had been vacci-
nated  times. Only 2 steers were cul-
ture positive from direct plating, both 
were from the placebo-treated group. 
Statistical tests of efficacy
Statistical tests of colonization and 
fecal quantification from direct plat-
ing were not done because there were 
too few positive observations among 
placebo-treated cattle to make valid 
inferences regarding vaccine efficacy. 
Pre-treatment pen-level prevalence of 
fecal shedding did not differ between 
pens of cattle in the three treatment 
groups, based on either a general-
ized linear mixed model with block 
as random effect, or a generalized 
estimation equation model defining 
correlation of pens within block. Post-
treatment vaccine efficacy was tested 
using three multilevel modeling ap-
proaches. Estimates of vaccine efficacy 
from each of the three models were 
nearly identical, based on least square 
means of the three model estimates. 
The significance of within-treat-
ment differences was nearly identi-
cal for each of the three models. The 
Figure 1. Unadjusted prevalence of E. coli O157:H7 fecal shedding as determined by enrichment 
culture, plotted by test period.
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Figure 2. Unadjusted mean pen-level prevalence of E. coli O157:H7 fecal shedding as determined by 
enrichment culture, plotted by treatment and test period. Error bars represent one SEM.
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The unadjusted mean prevalence of 
shedding by treatment and test period 
is summarized in Figure 2. The pen-
level prevalence of E. coli O157:H7 
fecal shedding during the post treat-
ment period was 9%, 6% and % for 
placebo-treated, 2-, and -dose vac-
cine regimens, respectively.
Quantification of E. coli O157:H7 shed 
in feces
Direct plating for quantification 
of E. coli O157:H7 was completed on 
a total of 1,961 pre- and post-treat-
ment fecal samples. The organism was 
detected in 29 of 1,961 samples (1.5%). (Continued on next page)
Page 104 — 2008 Nebraska Beef Report  © The Board of Regents of the University of Nebraska.  All rights reserved.
outcome of the first model is shown 
graphically in Figure .
The three-dose regimen signifi-
cantly reduced the probability for cat-
tle to shed E. coli O157:H7 in the feces 
6% compared to placebo treated cat-
tle. A dose-effect was demonstrated in 
that a 2-dose regimen of the vaccine 
product was intermediate in effect 
between placebo and a -dose regi-
men. These results are consistent with 
previous estimates of efficacy for fecal 
shedding and agree with our previous 
finding that efficacy of 2 or  doses of 
vaccine exhibit a dose-response.
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Figure 3. Model-adjusted post-treatment probabilities for cattle to shed E. coli O157:H7 in feces, 
determined by enrichment culture, by treatment. Error bars represent one SEM. Treatments 
with different superscripts differ, P < 0.05.
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